Arrowhead Pharmaceuticals Inc (ARWR)

Interest coverage

Sep 30, 2025 Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Earnings before interest and tax (EBIT) US$ in thousands -580,108 -188,165 -178,507 -140,846
Interest expense US$ in thousands 89,361 32,352 18,326 5,033 6,120
Interest coverage 0.00 -17.93 -10.27 -35.47 -23.01

September 30, 2025 calculation

Interest coverage = EBIT ÷ Interest expense
= $—K ÷ $89,361K
= 0.00